Le società scientifiche European Heart Rhythm Association (EHRA)/Heart Rhythm Society […]
Search Results for: Linee guida sulla radioterapia per glioma
Here's what we've found for you
Superati i 3 milioni di casi di dengue in Brasile, è record
Il Paese guida la statistica in America Latina. Oltre 1200 morti
Aggiornate le linee guida riguardanti l’uso della lipoproteina(a)
La National Lipid Association ha aggiornato le linee guida riguardanti l’uso […]
AGA: linee guida sulla de-prescrizione degli inibitori della pompa protonica
Gli inibitori della pompa protonica (PPI) sono tra i farmaci […]
Cannabis e cannabinoidi negli adulti affetti da cancro: linea guida
L’accesso e l’uso della cannabis e/o dei cannabinoidi da parte […]
Guida all’utilizzo del laboratorio di microbiologia per la diagnosi delle malattie infettive
Il laboratorio di microbiologia svolge un ruolo critico nella diagnosi […]
Il ruolo dell’imaging nel sanguinamento gastrointestinale: linea guida
Il sanguinamento gastrointestinale è la diagnosi più comune che porta […]
WHO: linee guida sull’infezione cronica da epatite B
Il WHO ha pubblicato nuove linee guida sulla prevenzione, diagnosi e […]
Terapia intensiva neonatale, guida per 'dimissioni felici'
Aiutando genitori si riduce rischio di nuovi accessi in ospedale
Disforia: Schillaci-Roccella, tavolo per nuove linee guida su triptorelina
Comunicato del 25/03/2024 n°20
Prime linee guida per Long Covid, riguardano il 6% dei pazienti
Progetto Pascnet contro la nuova emergenza di sanità pubblica
Adjuvant Wilms tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium
Introduction
Diffuse intrinsic pontine glioma (DIPG) and paediatric high-grade glioma (pHGG) are aggressive glial tumours, for which conventional treatment modalities fall short. Dendritic cell (DC)-based immunotherapy is being investigated as a promising and safe adjuvant therapy. The Wilms’ tumour protein (WT1) is a potent target for this type of antigen-specific immunotherapy and is overexpressed in DIPG and pHGG. Based on this, we designed a non-randomised phase I/II trial, assessing the feasibility and safety of WT1 mRNA-loaded DC (WT1/DC) immunotherapy in combination with conventional treatment in pHGG and DIPG.
Methods and analysis
10 paediatric patients with newly diagnosed or pretreated HGG or DIPG were treated according to the trial protocol. The trial protocol consists of leukapheresis of mononuclear cells, the manufacturing of autologous WT1/DC vaccines and the combination of WT1/DC-vaccine immunotherapy with conventional antiglioma treatment. In newly diagnosed patients, this comprises chemoradiation (oral temozolomide 90 mg/m2 daily+radiotherapy 54 Gy in 1.8 Gy fractions) followed by three induction WT1/DC vaccines (8–10×106 cells/vaccine) given on a weekly basis and a chemoimmunotherapy booster phase consisting of six 28-day cycles of oral temozolomide (150–200 mg/m2 on days 1–5) and a WT1/DC vaccine on day 21. In pretreated patients, the induction and booster phase are combined with best possible antiglioma treatment at hand. Primary objectives are to assess the feasibility of the production of mRNA-electroporated WT1/DC vaccines in this patient population and to assess the safety and feasibility of combining conventional antiglioma treatment with the proposed immunotherapy. Secondary objectives are to investigate in vivo immunogenicity of WT1/DC vaccination and to assess disease-specific and general quality of life.
Ethics and dissemination
The ethics committee of the Antwerp University Hospital and the University of Antwerp granted ethics approval. Results of the clinical trial will be shared through publication in a peer-reviewed journal and presentations at conferences.
Trial registration number
NCT04911621
Linee guida sulla valutazione e gestione della malattia renale cronica
Le linee guida per la pratica clinica KDIGO 2024 per […]
Linee guida sulla diagnosi e gestione del cancro al polmone
Questa linea guida pubblicata da NICE in aggiornamento, copre la […]
Trattamento dell’insufficienza cardiaca con frazione di eiezione ridotta
Sono state aggiornate a cura dell’American College of Cardiology le linee […]
Linea guida sulla gestione della pancreatite acuta
L’American College of Gastroenterology ha pubblicato sulla rivista “American Journal […]